Literature DB >> 12354861

Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Florence Damond1, Marie Gueudin, Sophie Pueyo, Isabelle Farfara, David L Robertson, Diane Descamps, Geneviève Chène, Sophie Matheron, Pauline Campa, Françoise Brun-Vézinet, François Simon.   

Abstract

Human immunodeficiency virus type 2 (HIV-2) is much less pathogenic than HIV-1, and HIV-2 infection is associated with plasma viral loads significantly lower than those found in HIV-1 infection. We have developed a real-time quantitative PCR method for measuring the HIV-2 RNA load that covers the range of genetic diversity of HIV-2 isolates and that detects extremely low viral loads. Samples from 49 patients were studied. Proviral DNA was first detected and quantified. The strains that were detected were then genotyped: 21 patients were infected with HIV-2 subtype A and 15 patients were infected with HIV-2 subtype B; 1 patient was infected with a highly divergent strain. Env PCR failed for the remaining 12 patients, so subtypes could not be determined. For viral RNA quantification, a stock of HIV-2 strain NIHZ, which was counted by electron microscopy, was used as the standard. Several primer sets targeting the highly conserved gag region were evaluated. Various primer combinations failed to amplify subtype B strains. With the final primer pair selected, which detected both subtype A and subtype B strains, the sensitivity of the assay was 100% at a viral load of 250 copies/ml and 66% at a viral load of 125 copies/ml. We found a correlation between the CD4(+)-cell count, the clinical stage, and the plasma HIV-2 RNA level. The median plasma HIV-2 RNA value for the 33 asymptomatic patients was 2.14 log(10), whereas it was 3.1 log(10) for the 16 patients with AIDS (P < 0.01). Proviral DNA was detectable in 18 symptom-free patients with high CD4(+)-cell counts, in whom viral RNA was undetectable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354861      PMCID: PMC130845          DOI: 10.1128/JCM.40.10.3654-3659.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA.

Authors:  F Damond; I Loussert-Ajaka; C Apetrei; D Descamps; S Souquière; A Leprêtre; S Matheron; F Brun-Vézinet; F Simon
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

2.  Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa.

Authors:  K Ariyoshi; S Jaffar; A S Alabi; N Berry; M Schim van der Loeff; S Sabally; P T N'Gom; T Corrah; R Tedder; H Whittle
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

3.  Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.

Authors:  S J Popper; A D Sarr; A Guèye-Ndiaye; S Mboup; M E Essex; P J Kanki
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load.

Authors:  V Soriano; P Gomes; W Heneine; A Holguín; M Doruana; R Antunes; K Mansinho; W M Switzer; C Araujo; V Shanmugam; H Lourenço; J González-Lahoz; F Antunes
Journal:  J Med Virol       Date:  2000-05       Impact factor: 2.327

5.  Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.

Authors:  F Damond; C Apetrei; D L Robertson; S Souquière; A Leprêtre; S Matheron; J C Plantier; F Brun-Vézinet; F Simon
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

6.  Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.

Authors:  F Damond; D Descamps; I Farfara; J N Telles; S Puyeo; P Campa; A Leprêtre; S Matheron; F Brun-Vezinet; F Simon
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma.

Authors:  M Schutten; B van den Hoogen; M E van der Ende; R A Gruters; A D Osterhaus; H G Niesters
Journal:  J Virol Methods       Date:  2000-07       Impact factor: 2.014

8.  Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.

Authors:  S J Popper; A D Sarr; K U Travers; A Guèye-Ndiaye; S Mboup; M E Essex; P J Kanki
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

9.  Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.

Authors:  S Andersson; H Norrgren; Z da Silva; A Biague; S Bamba; S Kwok; C Christopherson; G Biberfeld; J Albert
Journal:  Arch Intern Med       Date:  2000-11-27

10.  Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay.

Authors:  P Gomes; N C Taveira; J M Pereira; F Antunes; M O Ferreira; M H Lourenço
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

View more
  27 in total

1.  Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.

Authors:  F Damond; F Brun-Vezinet; S Matheron; G Peytavin; P Campa; S Pueyo; F Mammano; S Lastere; I Farfara; F Simon; G Chene; D Descamps
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay.

Authors:  Florence Damond; Gilles Collin; Diane Descamps; Sophie Matheron; Sophie Pueyo; Audrey Taieb; Pauline Campa; Antoine Benard; Geneviève Chêne; Francoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 3.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Fluorogenic LUX primer for quantitation of HIV-1 by real-time RT-PCR.

Authors:  Natela Rekhviashvili; Gwynneth Stevens; Lesley Scott; Wendy Stevens
Journal:  Mol Biotechnol       Date:  2006-02       Impact factor: 2.695

5.  CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.

Authors:  H Blaak; P H M Boers; R A Gruters; H Schuitemaker; M E van der Ende; A D M E Osterhaus
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection.

Authors:  Meredith Stewart; Moira Desport; Nining Hartaningsih; Graham Wilcox
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

7.  Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Authors:  Francois Rouet; Didier K Ekouevi; Marie-Laure Chaix; Marianne Burgard; Andre Inwoley; Thomas D'Aquin Tony; Christine Danel; Xavier Anglaret; Valeriane Leroy; Philippe Msellati; Francois Dabis; Christine Rouzioux
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

8.  Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients.

Authors:  Geoffrey S Gottlieb; Stephen E Hawes; Nancy B Kiviat; Papa Salif Sow
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

9.  Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.

Authors:  David Gautier; Stéphanie Beq; Catarina S Cortesão; Ana E Sousa; Rémi Cheynier
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

10.  Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.

Authors:  P Colson; M Henry; C Tourres; D Lozachmeur; H Gallais; J A Gastaut; J Moreau; C Tamalet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.